Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.
Gabelli International Growth C GCIGX
- NAV / 1-Day Return 19.76 / −0.55 %
- Total Assets 18.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 3.270%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Foreign Large Growth
- Investment Style Large Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield —
- Turnover 11%
USD | NAV as of Apr 18, 2024 | 1-Day Return as of Apr 18, 2024, 10:16 PM GMT+0
Morningstar’s Analysis GCIGX
Will GCIGX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Hermes International SA | 5.49 | 1.1 Mil | Consumer Cyclical |
Novo Nordisk A/S Class B | 5.36 | 1.1 Mil | Healthcare |
Christian Dior SE | 5.24 | 1.0 Mil | Consumer Cyclical |
Keyence Corp | 4.66 | 916,380 | Technology |
Compagnie Financiere Richemont SA Class A | 4.42 | 868,830 | Consumer Cyclical |
Nestle SA | 4.27 | 840,553 | Consumer Defensive |
L'Oreal SA | 4.05 | 795,992 | Consumer Defensive |
Investor AB Class B | 3.53 | 694,524 | Financial Services |
AstraZeneca PLC | 3.09 | 608,008 | Healthcare |
SMC Corp | 3.00 | 591,035 | Industrials |